Quadintel recently added a new market research report named “Bioresorbable Vascular Scaffold Market.” The research provides a thorough analysis of the global market in relation to the major growth-influencing opportunities and drivers. The study also maps emerging trends and their effects on current and forthcoming market developments.
The research sheds light on the industry-specific difficulties that the major companies and the Bioresorbable Vascular Scaffold market as a whole are now experiencing. This will eventually assist market players in making profitable investment decisions. Market analysts have researched the market using numerous market segmentations in order to help the main players comprehend its structure.
Global Bioresorbable Vascular Scaffold Market is valued at approximately USD $$ billion in 2021 and is anticipated to grow with a healthy growth rate of more than $% over the forecast period 2022-2030.
Request To Download Free Sample of This Strategic Report: –https://www.quadintel.com/request-sample/global-bioresorbable-vascular-scaffold-market/3-2-1146
The Bioresorbable Vascular Scaffold (BVS) is a non-metallic mesh tube that is generally used in the treatment of a narrowed artery. The BVC completely gets absorbed by the body leaving no foreign material. Factors such as the growing geriatric population and increasing incidences of target diseases such as rheumatic heart disease, coronary heart disease, peripheral arterial disease, cerebrovascular disease, congenital heart disease, and pulmonary embolism are driving the global market growth.
According to the World Health Organization (WHO), it was estimated that approximately 17.9 million people worldwide die every year because of cardiovascular diseases. Therefore, the high prevalence of CVDs is propelling the demand for Bioresorbable Vascular Scaffold, which, in turn, augments the market growth across the globe. In addition, rising technological advancements and a robust product pipeline are presenting lucrative opportunities for growth in the market during the forecast period. However, lack of awareness about bioresorbable vascular scaffolds and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Bioresorbable Vascular Scaffold Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the presence of skilled professionals and growing investment in R&D activities. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising expenditure on healthcare, as well as growing incidences of target diseases.
Download Free Sample of This Strategic Report: –https://www.quadintel.com/request-sample/global-bioresorbable-vascular-scaffold-market/3-2-1146
Major market players included in this report are:
- Meril Life Sciences
- Abbott
- Cook Medical
- Boston Scientific Corporation
- W.L. Gore & Associates, Inc.
- Medtronic
- Stentys SA
- MAQUET Holding B.V. & Co. KG (Getinge AB)
- B. Braun Melsungen AG
- Terumo Corporation
Recent Developments in the Market:
In May 2021, a study of patients with relatively simple coronary artery lesions unveils that some early promise for a new bioresorbable scaffold such as Firesorb, MicroPort Medical.
In January 2019, Reva Medical announced the expansion of the company’s commercial operations to seven additional European countries that are Estonia, Poland, Slovakia, Russia, Lithuania, the Czech Republic, and Latvia four new regional distribution partnerships.
Russia-Ukraine War Impact Analysis:
Global industries were impacted by the Russia-Ukraine War, which started in February 2022. There have been widespread announcements of strict travel restrictions over Ukrainian airspace. The market in 2022 has been damaged by the Russia-Ukraine War.
The conflict between Russia and Ukraine raises defense spending and fortifies NATO nations’ armed forces. Due to Russia’s invasion, the majority of European nations have raised their defense budget. Germany earmarked USD 109 billion, which is more than the whole cost of the military in 2021, increasing its defense spending above 2% of GDP.
Download Free Sample of This Strategic Report–https://www.quadintel.com/request-sample/global-bioresorbable-vascular-scaffold-market/3-2-1146
The detailed segments and sub-segment of the market are explained below:
By Application:
Peripheral Artery
Coronary Artery
By End User:
Hospitals
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
What is the key information extracted from the report?
- Extensive information on factors estimated to affect the Market growth and market share during the forecast period is presented in the report.
- The report offers the present scenario and future growth prospects Market in various geographical regions.
- The competitive landscape analysis on the market as well as the qualitative and quantitative information is delivered.
- The SWOT analysis is conducted along with Porter’s Five Force analysis.
- The in-depth analysis provides an insight into the Market, underlining the growth rate and opportunities offered in the business.
Request Full Report–https://www.quadintel.com/request-sample/global-bioresorbable-vascular-scaffold-market/3-2-1146
About Quadintel:
We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Quadintel:
Email:sales@quadintel.com
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website:https://www.quadintel.com/